UPC APP 11261/2025

—·EP2401365: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Case details: Status
—
Action
Preliminary objection
Category
Preliminary Objection
Parties: Claimants
Promosome LLC
Reps: Georg A. Rauh (Vossius & Partner)
Respondents
BioNTech SE
BioNTech Manufacturing GmbH
BioNTech Manufacturing Marburg GmbH
BioNTech Innovative Manufacturing Services GmbH
BioNTech Europe GmbH
Pfizer Manufacturing Belgium NV
Pfizer SAS
Pfizer AB
Pfizer, Inc.
Reps: Christine Kanz (Hoyng Rokh Monegier); Tobias J. Hessel (Clifford Chance Partnerschaft mbB)
Division: Munich LD
Judges: Andras Kupecz · Judge-rapporteur
Technology: Biotechnology
Language: —
First decided: Apr 17, 2025

Decisions

2025-04-17
JurisdictionalPreliminary objection
The Local Division Munich ruled on preliminary objections filed by BioNTech and Pfizer entities challenging UPC jurisdiction over Comirnaty COVID-19 vaccine variants sold before 1 June 2023, addressing the UPC's temporal jurisdiction in relation to the opt-out regime and the date of UPC operation.
Legal issues:Preliminary objection – jurisdiction (R.19 RoP)Temporal jurisdiction of UPCOpt-out regimeCOVID-19 vaccine infringement claim

Documents